Guidance

Subcategories:Clinical Criteria/Guidelines Ethics Legal Updates Legislation & Advocacy Meeting Reports Research Rheum

Arthritis Self-Management Program Success

Kurt Ullman | February 3, 2012

Although effective, arthritis self-management programs can be challenging to implement.

Shortcomings and Promises of Genome-wide Association Studies

Ann Kepler | February 3, 2012

The outcomes of genome-wide association studies (GWAS) have not been what scientists expected, but researchers are developing new approaches to use revelatory GWAS information to identify genetic causal variants, predictors of treatment response, and future opportunities for genetic insight.

A Passion for Multidisciplinary Collaboration

Gretchen Henkel | February 3, 2012

Through teamwork, David T. Felson, MD, MPH, has advanced understanding and treatment of rheumatic diseases

How A Social Media Policy Can Protect Your Practice

Steven M. Harris, Esq. | February 3, 2012

While social media can be a beneficial marketing tool, it is important for rheumatologists to address the proper ways to use this outreach both inside and outside the workplace through a specific media policy

Letter: RA Approval for IL-1Ra

William Arend, MD | February 3, 2012

Investors convinced the executives of Synergen that they needed to evaluate IL-1Ra for a disease with a more rapid outcome. RA studies were too slow to yield a quick profit. Thus, they picked sepsis syndrome.